European panel gives nod to engineered knee-repair product

04/29/2013 | Medscape (free registration)

The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended Genzyme's matrix-induced autologous chondrocyte implantation for marketing approval. The knee-repair product uses a porcine collagen scaffold seeded with autologous cartilage cells. The European Commission will make the final decision.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX